Sarepta’s stock sank after studies of Duchenne muscular dystrophy treatments failed their primary endpoints.
Raise
-
-
Governments around the world struggle with basic financial mathematics. In other words, many spend much more than they receive. Unlike individual households, who cannot continue to run cash deficits indefinitely…
-
StablecoinX and TLGY Acquisition have secured an additional $530 million in financing to buy digital assets, bringing total commitments to $890 million ahead of a planned merger and Nasdaq listing.…
-
Stocks
The stock market is turning into a casino — raise cash, and also buy this AI company, says strategist
Yves Lamoureux has shifted his view on stocks to neutral from “extremely bullish,” as he says investors have turned into gamblers.
-
Milestone Pharmaceuticals (NASDAQ:MIST) has launched a public offering to raise capital, that includes common shares, alongside both Series A and Series B warrants. For certain, investors will have the option…
-
Key Points Borrowers currently on SAVE, PAYE, or ICR will switch to RAP or IBR next year. Monthly payments could rise sharply for borrowers under these plans. Examples show some…
-
Gold was on the decline this week, closing just below US$3,370 per ounce, after tensions in the Middle East pushed it past the US$3,430 level toward the end of last…
-
Welcome to the first edition of the Investing News Network’s weekly round-up of Australia’s top-performing mining stocks on the ASX, starting with news in Australia’s resource sector. In significant news…
-
H&M’s second-largest market by revenue is the U.S., trailing Germany.
-
Investment
Right to Earn Majority Interest in Highly Prospective Chilean Copper-Gold-Molybdenite Porphyry Project and Placement to raise $2.2m
Highlights: The 2025 drill program is set to begin. A pipeline of large-scale exploration targets prioritized for drilling includes: Cirrus Deeps – high-priority EM target below the Cirrus Deposit with…
